Scientists in Germany have achieved a significant milestone in cellular biology by dramatically reversing the molecular age of human cells. Researchers at the University Hospital of Bonn and the University of Bonn successfully transformed blood cells from an 80-year-old donor into neural stem cells with a molecular age signature of less than 20 years. This process effectively reversed more than six decades of cellular aging.
Direct Conversion Without Pluripotent Stage
The study, led by Prof. Dr. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn, utilized a method that bypasses traditional reprogramming steps. Previous approaches typically involved converting mature cells into pluripotent stem cells, which have the potential to develop into any cell type in the body, before guiding them toward a specific identity. This two-stage process often results in rapid rejuvenation that is difficult to monitor in real time.
In contrast, the Bonn team converted immature red blood cell precursors directly into neural stem cells. This direct conversion allowed the researchers to track the changes over an extended period of more than 100 days. The gradual nature of this transformation provided a unique opportunity to observe the biological mechanisms of cellular rejuvenation as they unfolded, rather than simply observing the final outcome.
“In our current study, however, we focused on a different phenomenon: namely, the observation that cells become significantly rejuvenated during reprogramming,” Brüstle stated. The team observed a dramatic reduction in molecular age, with the cells showing signs of being over 60 years younger after just 50 days of the process.
Resetting Epigenetic Clocks
To measure the extent of the reversal, the researchers analyzed the cells’ epigenetic clocks. These molecular markers estimate biological age by examining chemical modifications to DNA that accumulate or change as organisms grow older. Unlike genetic mutations, these epigenetic changes do not alter the DNA sequence itself but affect how frequently certain genetic instructions are used.
After the reprogramming process, the cells taken from the elderly donor displayed molecular age signatures corresponding to individuals younger than 20. The researchers confirmed that this epigenetic rejuvenation ensured the cells behaved like young cells, retaining the functional characteristics associated with early development.
The human body contains hundreds of specialized cell types that originate from a single fertilized egg. As cells develop, they take on specific roles, and under normal circumstances, a blood cell cannot transform into a nerve cell. Modern laboratory techniques using transcription factors, which regulate gene activation, have made it possible to overcome these biological restrictions. By changing which genetic instructions a cell follows, scientists can redirect its development and give it a new cellular identity.
Implications for Neurodegenerative Disease Research
The ability to watch cells gradually become younger offers valuable insights into the mechanisms that control biological aging. Because the epigenetic clocks reset slowly over several weeks, this model allows scientists to investigate which factors and active substances can accelerate or slow down the rejuvenation process.
These findings are particularly relevant to neuroscience, where aging is the most significant risk factor for neurodegenerative diseases such as Alzheimer’s. Although the work does not establish a treatment capable of reversing aging in people, it provides a laboratory model for investigating how cells regain youthful characteristics. Previous experiments by the Bonn team demonstrated that nerve cells generated through this approach could successfully connect with existing neurons after being transplanted into the brains of mice.
The research involved teams from the University Hospital of Bonn, the University of Bonn, and RWTH Aachen University. Funding for the project was provided by the EU’s Horizon 2020 program, the German Research Foundation (DFG), and the Federal Ministry of Research, Technology, and Space (BMFRT). The study highlights the potential for using direct cellular conversion to better understand and potentially treat conditions linked to aging.
Source: ScienceDaily
